The immunology and immunopathology of COVID-19.
Journal
Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511
Informations de publication
Date de publication:
11 03 2022
11 03 2022
Historique:
entrez:
10
3
2022
pubmed:
11
3
2022
medline:
19
3
2022
Statut:
ppublish
Résumé
Considerable research effort has been made worldwide to decipher the immune response triggered upon severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, identify the drivers of severe and fatal COVID-19, and understand what leads to the prolongation of symptoms after disease resolution. We review the results of almost 2 years of COVID-19 immunology research and discuss definitive findings and remaining questions regarding our understanding of COVID-19 pathophysiology. We discuss emerging understanding of differences in immune responses seen in those with and without Long Covid syndrome, also known as post-acute sequelae of SARS-CoV-2. We hope that the knowledge gained from this COVID-19 research will be applied in studies of inflammatory processes involved in critical and chronic illnesses, which remain a major unmet need.
Identifiants
pubmed: 35271343
doi: 10.1126/science.abm8108
doi:
Substances chimiques
Antibodies, Monoclonal
0
Antiviral Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1122-1127Subventions
Organisme : NCI NIH HHS
ID : P30 CA196521
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI157488
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States